FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051440582> ?p ?o ?g. }

• W2051440582 endingPage "525" @default.
• W2051440582 startingPage "517" @default.
• W2051440582 abstract "Increased circulating soluble ICAM-1 (sICAM-1) levels has been previously reported in Graves' disease (GD) patients with or without ophthalmopathy (GO) and in patients with toxic nodular goiter but not in patients with subacute thyroiditis. Conflicting results have also been reported about the usefulness of sICAM-1 levels as a marker for the activity of hyperthyroidism. We have therefore determined sICAM-1 levels by a sandwich enzyme linked immunosorbent assay (ELISA) method in 10 patients with subacute thyroiditis (Group 1), who are at the initial or acute phase of thyroiditis, in 10 hypothyroidic patients with Hashimoto's thyroiditis (Group 2), in 10 patients with euthyroid nodular goiter (Group 3), in 10 patients with untreated GD patients with active ophthalmopathy (Group 4), in 10 hyperthyroid GD patients without clinical ophthalmopathy (Group 5), in 10 patients with GO who are euthyroid and treated with glucocorticoids for 3 months (Group 6) and in 20 normal subjects (Control Group). Groups 1,2,4,5 and 6 (P < 0.00001 for Groups 1,4,5,6 and P < 0.05 for Group 2) but not Group 3 showed increased sICAM-1 levels compared with the control group. However Groups 4 and 6 (patient with GO) showed significantly higher sICAM-1 levels (P = 0.0003 for Group 4 and P = 0.00013 for Group 6) than Group 5. Furthermore Group 4 showed slightly but not significantly higher sICAM-1 levels than Group 6. Mean sICAM levels were significantly decreased 3 months after glucocorticoid treatment (Group 6), but had not returned to normal levels. Three patients did not respond to steroid therapy and their sICAM-1 levels were not decreased. We concluded that patients with GO with or without hyperthyroidism and patients with subacute thyroiditis have elevated sICAM-1 levels. Moreover, sICAM-1 levels reflect the degree of inflammatory activity in the thyroid gland or orbital tissue independent of the thyroidal status, since we found elevated levels in both hyperthyroidism and hypothyroidism." @default.
• W2051440582 created "2016-06-24" @default.
• W2051440582 creator A5005275532 @default.
• W2051440582 creator A5027903902 @default.
• W2051440582 creator A5033520812 @default.
• W2051440582 creator A5041726032 @default.
• W2051440582 creator A5047562398 @default.
• W2051440582 creator A5048975588 @default.
• W2051440582 creator A5053919067 @default.
• W2051440582 creator A5067570475 @default.
• W2051440582 date "1996-01-01" @default.
• W2051440582 modified "2023-10-17" @default.
• W2051440582 title "Soluble Intercellular Adhesion Molecule-1 Concentrations in Patients with Subacute Thyroiditis and in Patients with Graves' Disease with or without Ophthalmopathy." @default.
• W2051440582 cites W1530281430 @default.
• W2051440582 cites W1578438134 @default.
• W2051440582 cites W1607729794 @default.
• W2051440582 cites W1966286149 @default.
• W2051440582 cites W1978552744 @default.
• W2051440582 cites W1981297743 @default.
• W2051440582 cites W1995948010 @default.
• W2051440582 cites W1996255823 @default.
• W2051440582 cites W1999375867 @default.
• W2051440582 cites W1999993136 @default.
• W2051440582 cites W2004186787 @default.
• W2051440582 cites W2014090782 @default.
• W2051440582 cites W2020319987 @default.
• W2051440582 cites W2020845648 @default.
• W2051440582 cites W2022205162 @default.
• W2051440582 cites W2028418732 @default.
• W2051440582 cites W2041452685 @default.
• W2051440582 cites W2043137752 @default.
• W2051440582 cites W2044150349 @default.
• W2051440582 cites W2045283830 @default.
• W2051440582 cites W2050941612 @default.
• W2051440582 cites W2051104028 @default.
• W2051440582 cites W2053886667 @default.
• W2051440582 cites W2057784785 @default.
• W2051440582 cites W2078181710 @default.
• W2051440582 cites W2078526189 @default.
• W2051440582 cites W2079041842 @default.
• W2051440582 cites W2091950481 @default.
• W2051440582 cites W2110453451 @default.
• W2051440582 cites W2123246253 @default.
• W2051440582 cites W2135723979 @default.
• W2051440582 cites W2320293007 @default.
• W2051440582 cites W2463578090 @default.
• W2051440582 doi "https://doi.org/10.1507/endocrj.43.517" @default.
• W2051440582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8980891" @default.
• W2051440582 hasPublicationYear "1996" @default.
• W2051440582 type Work @default.
• W2051440582 sameAs 2051440582 @default.
• W2051440582 citedByCount "14" @default.
• W2051440582 countsByYear W20514405822016 @default.
• W2051440582 countsByYear W20514405822021 @default.
• W2051440582 countsByYear W20514405822022 @default.
• W2051440582 crossrefType "journal-article" @default.
• W2051440582 hasAuthorship W2051440582A5005275532 @default.
• W2051440582 hasAuthorship W2051440582A5027903902 @default.
• W2051440582 hasAuthorship W2051440582A5033520812 @default.
• W2051440582 hasAuthorship W2051440582A5041726032 @default.
• W2051440582 hasAuthorship W2051440582A5047562398 @default.
• W2051440582 hasAuthorship W2051440582A5048975588 @default.
• W2051440582 hasAuthorship W2051440582A5053919067 @default.
• W2051440582 hasAuthorship W2051440582A5067570475 @default.
• W2051440582 hasBestOaLocation W20514405821 @default.
• W2051440582 hasConcept C126322002 @default.
• W2051440582 hasConcept C134018914 @default.
• W2051440582 hasConcept C2776216339 @default.
• W2051440582 hasConcept C2776254400 @default.
• W2051440582 hasConcept C2776652619 @default.
• W2051440582 hasConcept C2776685619 @default.
• W2051440582 hasConcept C2777195454 @default.
• W2051440582 hasConcept C2777785397 @default.
• W2051440582 hasConcept C2778696486 @default.
• W2051440582 hasConcept C2780678043 @default.
• W2051440582 hasConcept C2780841215 @default.
• W2051440582 hasConcept C526584372 @default.
• W2051440582 hasConcept C71924100 @default.
• W2051440582 hasConcept C90924648 @default.
• W2051440582 hasConceptScore W2051440582C126322002 @default.
• W2051440582 hasConceptScore W2051440582C134018914 @default.
• W2051440582 hasConceptScore W2051440582C2776216339 @default.
• W2051440582 hasConceptScore W2051440582C2776254400 @default.
• W2051440582 hasConceptScore W2051440582C2776652619 @default.
• W2051440582 hasConceptScore W2051440582C2776685619 @default.
• W2051440582 hasConceptScore W2051440582C2777195454 @default.
• W2051440582 hasConceptScore W2051440582C2777785397 @default.
• W2051440582 hasConceptScore W2051440582C2778696486 @default.
• W2051440582 hasConceptScore W2051440582C2780678043 @default.
• W2051440582 hasConceptScore W2051440582C2780841215 @default.
• W2051440582 hasConceptScore W2051440582C526584372 @default.
• W2051440582 hasConceptScore W2051440582C71924100 @default.
• W2051440582 hasConceptScore W2051440582C90924648 @default.
• W2051440582 hasIssue "5" @default.
• W2051440582 hasLocation W20514405821 @default.
• W2051440582 hasLocation W20514405822 @default.
• W2051440582 hasOpenAccess W2051440582 @default.
• W2051440582 hasPrimaryLocation W20514405821 @default.

• next